Vanguard reports 0 AORT shares after internal realignment (NASDAQ: AORT)
Rhea-AI Filing Summary
Artivion Inc received Amendment No. 6 to a Schedule 13G/A from The Vanguard Group that reports zero shares beneficially owned of Common Stock and 0% of the class. The filing reflects an internal realignment on January 12, 2026 under SEC Release No. 34-39538, after which certain Vanguard subsidiaries will report holdings separately. The filing lists Vanguard's Malvern, PA address and states that no single other person holds more than 5% of the class. The form is signed by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.
Positive
- None.
Negative
- None.
Insights
Amendment documents a reclassification of beneficial ownership and reports no holdings.
The amendment updates reporting to reflect an internal Vanguard realignment effective January 12, 2026, citing SEC Release No. 34-39538. The statement clarifies that certain subsidiaries now report separately and Vanguard disclaims beneficial ownership of those accounts.
Filing mechanics: the form lists 0 shares and 0%, and includes the signer’s title and date. Subsequent public filings from the disaggregated entities will show any holdings previously aggregated here.
Reported position is zero, indicating no current Vanguard stake reported on this Schedule 13G/A.
The filing states Amount beneficially owned: 0 and Percent of class: 0%. It also affirms that no other person's interest exceeds 5% within the reported accounts.
Investor implications depend on future disclosures by the Vanguard subsidiaries that now report separately; this amendment itself does not show holdings or trading activity.
FAQ
What does Artivion (AORT) Schedule 13G/A Amendment No. 6 report?
Does the AORT filing indicate any party holds more than 5%?
Who signed the Artivion (AORT) amendment and when was it signed?
Will Vanguard’s disaggregated subsidiaries report AORT holdings separately?